Sharecast
United Kingdom
Italian
Spanish
Portuguese
French
German
Chinese (Sim.)
Chinese (Tra.)
Russian
Danish
Croatian
Dutch
Finnish
Japanese
Swedish
Norwegian
Polish
Romanian
Serbian
Turkish
Indonesian
Bosnian
Bulgarian
Catalan
Czech
Greek
Afrikaans
Albanian
Amharic
Arabic
Armenian
Azerbaijani
Basque
Belarusian
Bengali
Cebuano
Chichewa
Corsican
sharecast
Summary
Sector
Pharma and Biotech
Indices
FTSE AIM
Ondine Biomedical Inc. NPV (CDI) (OBI)
12.50p
16:55 31/01/25
4.17%
0.50p
Today's Low & High
12.00
/
12.85
Open / Previous Close
12.00 / 12.50
52-week range
19.05%
2.00p
Volume
662,568
Market Cap(million)
£55.25m
Advertising
Summary
KEY FINANCIALS
Income & Efficiency
Valuation
Growth
Latest
Forecast
Div Yield
0.0%
n/a
Div Cover
n/a
n/a
Op Mrgn
-1,230.7%
n/a
ROCE
0.0%
Latest
Forecast
P/E
-2.2
n/a
PEG
0.0
n/a
Price / Revenue
57.2
n/a
Price / Book value
33.0
Latest
Forecast
Revenue
88.6%
n/a
PBT
0.0%
n/a
EPS
0.0%
n/a
DPS
n/a
n/a
KEY FUNDAMENTALS
Year Ending
Revenue
($m)
Pre-tax
($m)
EPS
P/E
PEG
EPS Growth
Div
Yield
2020-12-31
1.79
-16.27
$-0.23
0.0
0.0
n/a
n/a
0.0%
2021-12-31
2.57
-50.08
$-0.63
-1.5
0.0
n/a
n/a
0.0%
2022-12-31
0.64
-19.37
$-0.10
-2.5
0.0
n/a
n/a
0.0%
2023-12-31
1.20
-14.41
$-0.07
-1.6
0.0
n/a
n/a
0.0%
Latest Webfg News
Ondine Biomedical gets $4m investment from HCA Healthcare subsidiary
Sharecast News
27 Jan
Ondine enrols first patient in phase three clinical trial
Sharecast News
30 Dec
Ondine Biomedical to start phase three Steriwave clinical trial
Sharecast News
17 Dec
More Webfg News
Regulatory News
CEO Increases Stake in Ondine
31-Jan-25 10:04
Replacement: Director Increases Stake in Ondine
31-Jan-25 09:52
Director Increases Stake in Ondine
31-Jan-25 07:01
Notification of Major Holdings
30-Jan-25 17:49
Notification of Major Holdings
29-Jan-25 17:00
read more news
Loading:
Login with Facebook
Login with Google
o
Log in
Remember me
Forgot password?
Don’t have an account?
Sign In